Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | BAD | Q92934 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | FYN | P06241 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6749423 | 0.78 | BCL2L1 (0.41) | BCL2L1BADALDH1A1ALOX15HSD17B10 | |
| SCHEMBL9304448 | 0.78 | BCL2L1 (0.36) | BCL2L1BADALDH1A1ALOX15HSD17B10 | |
| SCHEMBL29503115 | 0.75 | CDK2 (0.36) | ALDH1A1HSD17B10HPGDCDK2CYP3A4 | |
| SCHEMBL276578 | 0.74 | SLC6A2 (0.35) | SLC6A2HTR2ASLC6A4HRH1OPRD1 | |
| SCHEMBL972273 | 0.74 | ALDH1A1 (0.35) | ALDH1A1ALOX15HSD17B10TDP1LMNA | |
| SCHEMBL11662214 | 0.73 | CYP3A4 (0.35) | ALDH1A1ALOX15HSD17B10TDP1HPGD | |
| SCHEMBL8765141 | 0.73 | SLC6A2 (0.34) | SLC6A2HTR2ASLC6A4HRH1OPRD1 | |
| SCHEMBL2974474 | 0.73 | TRPA1 (0.36) | SLC6A2HTR2ASLC6A4HRH1OPRD1 | |
| SCHEMBL3784850 | 0.73 | CYP1A2 (0.35) | ALDH1A1TDP1LMNARECQLSLC6A2 | |
| SCHEMBL31285053 | 0.73 | TRPA1 (0.36) | SLC6A2HTR2ASLC6A4HRH1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296912-A1 | AFFINITY ILLUDOFULVENE CONJUGATES | Illudent, Inc. (US) | 2025-09-25 | — | — | US | disclosed |
| US-12269793-B2 | Affinity illudofulvene conjugates | AF CHEMICALS, LLC (US) | 2025-04-08 | — | — | US | disclosed |
| US-20230212113-A1 | AFFINITY ILLUDOFULVENE CONJUGATES | AF Chemicals, LLC, (US) | 2023-07-06 | — | — | US | disclosed |
| US-20230159766-A1 | CONDUCTIVE POLYMER COMPOSITION, SUBSTRATE, AND METHOD FOR PRODUCING SUBSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-25 | — | — | US | disclosed |
| US-11208509-B2 | Polymer compound for conductive polymer and method for producing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-12-28 | — | — | US | disclosed |
| CN-112105654-A | Curable resin mixture, curable resin composition, and cured product thereof | 日本化药株式会社 | 2020-12-18 | — | — | CN | disclosed |
| US-20200291145-A1 | POLYMER COMPOUND FOR CONDUCTIVE POLYMER AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-09-17 | — | — | US | disclosed |
| US-20200259094-A1 | CONDUCTIVE POLYMER COMPOSITE AND CONDUCTIVE POLYMER COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-13 | — | — | US | disclosed |
| US-20200247926-A1 | POLYMERIZABLE MONOMER, POLYMER COMPOUND FOR CONDUCTIVE POLYMER, AND METHOD FOR PRODUCING THE POLYMER COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-06 | — | — | US | disclosed |
| WO-2020031935-A1 | CURABLE RESIN MIXTURE, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | 日本化薬株式会社 | 2020-02-13 | — | — | WO | disclosed |
| EP-0375560-A1 | Aryloxypropanolaminotetralines, process for their preparation and pharmaceutical compositions containing same | ELF SANOFI (FR) | 1990-06-27 | — | — | EP | disclosed |
| US-4904752-A | Liquid crystal copolyester having blocked molecular chain terminal | POLYPLASTICS CO., LTD. (JP) | 1990-02-27 | — | — | US | disclosed |
| EP-0269321-A2 | Liquid crystal copolyesters having a blocked terminal of its molecular chain | POLYPLASTICS CO. LTD. (JP) | 1988-06-01 | — | — | EP | disclosed |
| EP-0032706-B1 | INDAN-4-YL-N ALKYL CARBAMATES, METHOD FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1983-08-31 | — | — | EP | disclosed |
| EP-0032706-A2 | Indan-4-yl-N alkyl carbamates, method for their preparation and their use as fungicides | BAYER AG (DE) | 1981-07-29 | — | — | EP | disclosed |
| EP-0000936-A1 | 4-Indanyl esters of N-alkyl carbamic acid, processes for their preparation and their use as pesticides | BAYER AG (DE) | 1979-03-07 | — | — | EP | disclosed |
| US-4127675-A | BETA-RECEPTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1978-11-28 | — | — | US | disclosed |
| US-4045482-A | ADRENERGIC B-RECEPTOR BLOCKING AGENTS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JA) | 1977-08-30 | — | — | US | disclosed |
| US-3965182-A | Preparation of aniline from phenol and ammonia | ETHYL CORPORATION (US) | 1976-06-22 | — | — | US | disclosed |
| US-3931298-A | FROM A HYDROXYAROMATIC AND AMMONIA, GROUP 8-CYCLOHEXANONE CATALYST | ETHYL CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296912-A1 | AFFINITY ILLUDOFULVENE CONJUGATES | OGFR, TNFSF11, FCER2 | BCL2L1 1509/4885BAD 420/4885ALDH1A1 4400/4885 |
| US-20200247926-A1 | POLYMERIZABLE MONOMER, POLYMER COMPOUND FOR CONDUCTIVE POLYMER, AND METHOD FOR PRODUCING THE POLYMER COMPOUND | HCN4, HCN2, HCN3 | BCL2L1 3681/4885BAD 4192/4885ALDH1A1 2526/4885 |
| US-20230212113-A1 | AFFINITY ILLUDOFULVENE CONJUGATES | OGFR, TNFSF11, FCER2 | BCL2L1 1509/4885BAD 420/4885ALDH1A1 4400/4885 |
| US-12269793-B2 | Affinity illudofulvene conjugates | OGFR, TNFSF11, FCER2 | BCL2L1 1509/4885BAD 420/4885ALDH1A1 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.